Related Experiment Videos
Molecular biology and gene transfer in atherosclerosis in the stenting era
Noel M Caplice1, Robert D Simari, David R Holmes
1Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN.
Insights
Molecular biology and gene technology revolutionize atherosclerosis research. These advances promise earlier genetic predisposition identification and tailored cardiovascular medicine strategies.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Genetics
Background:
- Atherosclerosis is a leading cause of mortality globally.
- Understanding its pathogenesis remains a significant challenge in cardiovascular research.
- Advances in cell and molecular biology have enhanced comprehension of the disease.
Purpose of the Study:
- To highlight the impact of molecular biology and gene technology on atherosclerosis research.
- To explore the potential of these technologies in cardiovascular medicine.
- To discuss future applications in disease prevention and treatment.
Main Methods:
- Review of scientific literature on atherosclerosis pathogenesis.
- Analysis of the application of molecular biology techniques.
- Examination of gene technology's role in cardiovascular research.
Main Results:
- Molecular biology and gene technology offer unprecedented insights into atherosclerosis.
- These technologies facilitate the identification of genetic predispositions.
- New avenues for preventive and therapeutic strategies are emerging.
Conclusions:
- The integration of molecular biology and gene technology is transforming cardiovascular medicine.
- Future research holds promise for earlier diagnosis and personalized treatment of atherosclerosis.
- These advancements are crucial for combating cardiovascular disease mortality.
Abstract:
Atherosclerosis is the major cause of death in the developed world. Understanding the pathogenesis of atherosclerosis has been a major challenge to cardiovascular research over the past several decades. During this period a number of advances in various scientific disciplines has increased our understanding of this disease. These include improved understanding of the structural and functional components of normal vessel wall and more recently the use of cell biology and molecular biology techniques to elucidate the pathogenesis of atherosclerosis. None of these advances has been more dramatic nor has potentially more far reaching consequences as the application of molecular biology and gene technology to the practice of cardiovascular medicine. These developments have already opened new and exciting areas of vascular research and may in the future provide for earlier identification of genetic predisposition to atherosclerosis, strategic planning of preventive therapy and more tailored pharmacologic approaches for established disease.